Encapsulated Glioma — Trials

Encapsulated Glioma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 116
Recruiting: 55
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–46 of 46 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03969706	Abemaciclib in Patients With Oligodendroglioma	completed	Phase 2	10	Stephen Bagley, MD, MSCEOTHER	1	Sep 25, 2026	clinicaltrials
NCT03194906	Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors	completed	Phase 2	41	St. Jude Children's Research HospitalOTHER	1	Jun 23, 2026	clinicaltrials